Private company

VBI Vaccines Inc/BC

VBI Vaccines Inc/BC is a Canadian pharmaceutical preparations company based in Cambridge.1

Last updated Oct 20, 2026.

Overview

  • IndustryPharmaceutical Preparations1
  • HeadquartersCambridge, Massachusetts1
  • Incorporated inBritish Columbia, Canada2
  • Business address160 Second Street, Cambridge, Cambridge, Ma 021422
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

(“MERS”); and (3) SARS-CoV, identified in 2002 as the cause of Severe Acute Respiratory Syndrome (“SARS”).3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-920.4%Operating margin4
-1069.3%Net margin4
702.4%Revenue growth, 20234
-1233.4%Return on equity4
6.74×Debt to equity4
-$61.8MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Research and development16¢$9.3M
  • Selling, general and admin73¢$42.1M
  • Interest11¢$6.4M

Out of $8.7M in revenue.4 The company lost money this year.

Financial statements

Revenue567894$8.7M in 2023+904% since 2017
0$2.5M$5.0M$7.5M$10.0M2017: $865.0K$865.0K20172018: $3.4M$3.4M2018+288%2019: $2.2M$2.2M2019−34%2020: $1.1M$1.1M2020−52%2021: $631.0K$631.0K2021−41%2022: $1.1M$1.1M2022+71%2023: $8.7M$8.7M2023+702%
Operating income567894-$79.9M in 2023+114% since 2017
-$100.0M-$75.0M-$50.0M-$25.0M02017: -$37.3M-$37.3M20172018: -$60.4M-$60.4M2018+62%2019: -$52.4M-$52.4M2019−13%2020: -$43.6M-$43.6M2020−17%2021: -$68.0M-$68.0M2021+56%2022: -$81.8M-$81.8M2022+20%2023: -$79.9M-$79.9M2023−2%
Net income567894-$92.8M in 2023+138% since 2017
-$150.0M-$100.0M-$50.0M02017: -$39.0M-$39.0M20172018: -$63.6M-$63.6M2018+63%2019: -$54.8M-$54.8M2019−14%2020: -$46.2M-$46.2M2020−16%2021: -$69.8M-$69.8M2021+51%2022: -$113.3M-$113.3M2022+62%2023: -$92.8M-$92.8M2023−18%
Fiscal year2017201820192020202120222023
Revenue$865.0K5$3.4M6$2.2M7$1.1M8$631.0K9$1.1M4$8.7M4
Cost of revenue$5.2M5$4.5M6$7.9M7$9.2M7
Research and development$20.9M5$38.5M6$26.3M7$14.9M8$19.6M9$15.5M4$9.3M4
Selling, general and admin$38.3M9$56.1M4$42.1M4
Operating expenses$68.7M9$82.9M4$88.6M4
Operating income-$37.3M5-$60.4M6-$52.4M7-$43.6M8-$68.0M9-$81.8M4-$79.9M4
Interest$2.9M5$2.6M6$2.2M7$2.7M8$4.7M9$4.0M4$6.4M4
Income before tax-$69.8M9-$113.3M4-$92.8M4
Income tax-$431.0K5
Net income-$39.0M5-$63.6M6-$54.8M7-$46.2M8-$69.8M9-$113.3M4-$92.8M4
Earnings per share-$0.279-$0.449-$6.034
Earnings per share (diluted)-$13.164-$6.034
Shares (weighted, basic)254.9M shares9258.3M shares915.6M shares4
Shares (weighted, diluted)8.6M shares415.6M shares4

Compare VBI Vaccines Inc/BC with another company

Corporate structure

VBI Vaccines Inc/BC sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of VBI Vaccines Inc/BC

  • PERCEPTIVE ADVISORS LLC Filed SC 13D/A on VBI Vaccines Inc/BC, latest Apr 17, 2024 (3 filings since Apr 7, 2023)
  • Brii Biosciences Ltd Filed SC 13G on VBI Vaccines Inc/BC, latest Jul 20, 2023
  • State Street Corporation Filed SC 13G/A on VBI Vaccines Inc/BC, latest Feb 10, 2022
  • VBI Vaccines Inc/BC Cambridge, Massachusetts

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What VBI Vaccines Inc/BC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$20.1M4 Dec 31, 2023$20.2M4 Dec 31, 2022−0.9%
Accumulated depreciation$10.4M4 Dec 31, 2023$8.0M4 Dec 31, 2022+30.1%
Property and equipment, net$9.7M4 Dec 31, 2023$12.3M4 Dec 31, 2022−21.1%
Operating-lease assets (leased space)$2.2M4 Dec 31, 2023$3.3M4 Dec 31, 2022−32.2%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$1.1M4 Dec 31, 2023$2.1M4 Dec 31, 2022−46.9%
Intangible assets, net (excluding goodwill)$36.5M4 Dec 31, 2023$58.3M4 Dec 31, 2022−37.4%
Finite-lived intangibles, gross$62.2M9 Dec 31, 2022$62.2M9 Dec 31, 20210%
Accumulated amortization-$669.0K9 Dec 31, 2022-$660.0K9 Dec 31, 2021−1.4%
Finite-lived intangibles, net$58.3M9 Dec 31, 2022$62.1M9 Dec 31, 2021−6.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$8.5M4 Dec 31, 2023$6.6M4 Dec 31, 2022+28.8%
Work in process$2.7M4 Dec 31, 2023$1.9M4 Dec 31, 2022+46.3%
Finished goods$1.7M4 Dec 31, 2023$893.0K4 Dec 31, 2022+86.0%

Leadership

Who has led VBI Vaccines Inc/BC, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Jeff Baxter2017–2023

President

  1. Jeff Baxter2017–2023

Chief financial officer

  1. Egidio Nascimento2017
  2. Christopher McNulty2018–2023
  3. Nell Beattie2023
20202025
Board members and other officers (21)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • DirectorMichel R. De Wilde named Sep 28, 202238
  • DirectorSteven R. Gillis named Sep 28, 202238

Former names

  • SciVac Therapeutics Inc.Jul 20, 2015 to Jun 13, 20162
  • LEVON RESOURCES LTD.Sep 10, 2010 to Jul 17, 20152
  • LEVON RESOURCES LTDNov 4, 2005 to Sep 7, 20102

Timeline

  1. Jan 3, 20258-K Completed an acquisition or sale; Change to shareholders' rights; Change in control39
  2. Dec 10, 20248-K Other events40
  3. Aug 2, 20248-K Bankruptcy or receivership; Listing notice or transfer; Other events41
  4. Jul 30, 20248-K Bankruptcy or receivership; New debt or obligation; Debt or obligation accelerated42
  5. Jun 25, 20248-K Shareholder vote; Other events43
  6. May 29, 20248-K Regulation FD disclosure44
  7. May 24, 20248-K Listing notice or transfer45
  8. May 15, 20248-K Entered a material agreement; Ended a material agreement; Results of operations46
  9. May 1, 20248-K Other events47
  10. Apr 16, 20248-K Results of operations48
  11. Apr 11, 20248-K Entered a material agreement; Results of operations; Regulation FD disclosure49
  12. Apr 3, 20248-K Regulation FD disclosure50
  13. Apr 27, 2017New chief executive Jeff Baxter becomes CEO15

Calendar

When it reported results

  1. May 15, 2024Reported quarterly or annual results46
  2. Apr 16, 2024Reported quarterly or annual results48
  3. Apr 11, 2024Reported quarterly or annual results49
  4. Nov 14, 2023Reported quarterly or annual results51
  5. Aug 14, 2023Reported quarterly or annual results52
  6. May 15, 2023Reported quarterly or annual results53
  7. Mar 13, 2023Reported quarterly or annual results54
  8. Nov 10, 2022Reported quarterly or annual results55

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

180 filings to the SEC since October 2021: 3 annual reports, 8 quarterly reports, 86 major events, 44 insider forms, 8 large holders, 1 private raises, 30 other. The latest 20:

  1. Jan 8, 2025EFFECT EDGAR
  2. Jan 3, 20258-K EDGAR
  3. Jan 3, 2025POS AM EDGAR
  4. Jan 3, 2025S-8 POS EDGAR
  5. Jan 3, 2025S-8 POS EDGAR
  6. Jan 3, 2025S-8 POS EDGAR
  7. Jan 3, 2025S-8 POS EDGAR
  8. Jan 3, 2025S-8 POS EDGAR
  9. Dec 10, 20248-K EDGAR
  10. Sep 6, 202425-NSE EDGAR
  11. Aug 2, 20248-K EDGAR
  12. Jul 30, 20248-K EDGAR
  13. Jun 25, 20248-K EDGAR
  14. May 29, 20248-K EDGAR
  15. May 24, 20248-K EDGAR
  16. May 15, 20248-K EDGAR
  17. May 15, 2024424B5 EDGAR
  18. May 15, 202410-Q EDGAR
  19. May 1, 20248-K EDGAR
  20. Apr 29, 2024ARS EDGAR

The 180 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

6 open-market trades by officers, directors and large owners since October 2021: 2 buys and 4 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jul 10, 2023GILLIS STEVENDirectorBuy609,090$1.65$1.0MForm 4
Apr 6, 2023PERCEPTIVE ADVISORS LLC10% ownerSale4,251,563$0.11$467.7KForm 4
Apr 5, 2023PERCEPTIVE ADVISORS LLC10% ownerSale1,832,563$0.13$238.2KForm 4
Apr 4, 2023PERCEPTIVE ADVISORS LLC10% ownerSale4,810,623$0.16$769.7KForm 4
Dec 3, 2021Beattie NellCFO, Head of Corp. DevelopmentBuy8,200$2.45$20.1KForm 4
Dec 1, 2021EDELMAN JOSEPH10% ownerSale2,707,463$3.31$9.0MForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Sep 14, 2022Filed a private offering of equity Form D: 1 investor so far Form D

SEC filer profile

How VBI Vaccines Inc/BC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARVBI Vaccines Inc/BC1
  • CIK0000764195
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inBritish Columbia, Canada1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address160 Second Street, Cambridge, Cambridge, MA 021421
  • Phone617-830-30311
  • Shares outstanding28,682,275 as of May 15, 202412
  • Public float$22.0M as of Jun 30, 20234
  • On EDGAR sinceNov 4, 20051
  • Filings855 in all: 8-K (245), 6-K (206), 4 (167), 3 (25), 10-Q (22), CORRESP (17), 424B5 (15), 20-F (13)1
    All 42 form types

    SC 13D/A (13), UPLOAD (13), DEFA14A (11), 425 (10), SC 13G (9), 10-K (8), D (8), DEF 14A (8), SC 13G/A (8), F-4/A (7), EFFECT (6), NT 20-F (5), S-8 (5), S-8 POS (5), PRE 14A (3), S-3 (3), 20-F/A (2), 4/A (2), 6-K/A (2), ARS (2), SC 13D (2), 10-K/A (1), 25-NSE (1), 424B3 (1), 8-A12B (1), 8-K/A (1), ARS/A (1), CERTNAS (1), CT ORDER (1), F-3 (1), F-4 (1), NT 10-K (1), POS AM (1), S-3ASR (1)

  • Latest filingsAnnual report (10-K) Apr 16, 2024
    Quarterly report (10-Q) May 15, 2024
    Proxy statement (DEF 14A) Apr 29, 2024
    Latest 8-K (8-K) Jan 3, 2025

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
    SEC EDGAROther events
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
    SEC EDGAROther events
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58